Asst. Professor Internal Medicine and Pharmacology
Raleigh, NC
Duke University Medical Center
Asst. Professor Internal Medicine and Pharmacology
GSK
Vice President, Clinical Safety-Pharmacovigilance at GSK
GSK
Medical Director
Furiex Pharmaceuticals (FURX: Nasdaq); acquired by Actavis for $1.2B
President, Chief Medical Officer and Board Director
Hatteras Venture Partners
Executive-in-Residence, consultant
GSK
Scientific Licensing, Business Development
Numerous biopharma companies and clients
Chief Med Officer-Redhill Biopharma; Board Member, C level exec. Frmr President, CMO Furiex Pharmac
Smith College
Stanford University School of Medicine
Mt. Sinai School of Medicine (now Icahn School of Medicine)
